Co-Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Co-Diagnostics and buy or sell other stocks, ETFs, and their options commission-free!About CODX
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
CEODwight Howard Egan
CEODwight Howard Egan
Employees132
Employees132
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2013
Founded2013
Employees132
Employees132
CODX Key Statistics
Market cap143.71M
Market cap143.71M
Price-Earnings ratio-5.28
Price-Earnings ratio-5.28
Dividend yield—
Dividend yield—
Average volume2.27M
Average volume2.27M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.55
52 Week high$1.55
52 Week low$0.1657
52 Week low$0.1657
Stock Snapshot
The current Co-Diagnostics(CODX) stock price is $2.36, with a market capitalization of 143.71M. The stock trades at a price-to-earnings (P/E) ratio of -5.28.
On 2026-01-14, Co-Diagnostics(CODX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.27M.
The stock's 52-week range extends from a low of $0.17 to a high of $1.55.
The stock's 52-week range extends from a low of $0.17 to a high of $1.55.
People also own
Based on the portfolios of people who own CODX. This list is generated using Robinhood data, and it’s not a recommendation.